276 related articles for article (PubMed ID: 34635154)
1. Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.
Sheng T; Ho SWT; Ooi WF; Xu C; Xing M; Padmanabhan N; Huang KK; Ma L; Ray M; Guo YA; Sim NL; Anene-Nzelu CG; Chang MM; Razavi-Mohseni M; Beer MA; Foo RSY; Sundar R; Chan YH; Tan ALK; Ong X; Skanderup AJ; White KP; Jha S; Tan P
Genome Med; 2021 Oct; 13(1):158. PubMed ID: 34635154
[TBL] [Abstract][Full Text] [Related]
2. Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent
Ooi WF; Nargund AM; Lim KJ; Zhang S; Xing M; Mandoli A; Lim JQ; Ho SWT; Guo Y; Yao X; Lin SJ; Nandi T; Xu C; Ong X; Lee M; Tan AL; Lam YN; Teo JX; Kaneda A; White KP; Lim WK; Rozen SG; Teh BT; Li S; Skanderup AJ; Tan P
Gut; 2020 Jun; 69(6):1039-1052. PubMed ID: 31542774
[TBL] [Abstract][Full Text] [Related]
3. Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities.
Ho SWT; Sheng T; Xing M; Ooi WF; Xu C; Sundar R; Huang KK; Li Z; Kumar V; Ramnarayanan K; Zhu F; Srivastava S; Isa ZFBA; Anene-Nzelu CG; Razavi-Mohseni M; Shigaki D; Ma H; Tan ALK; Ong X; Lee MH; Tay ST; Guo YA; Huang W; Li S; Beer MA; Foo RSY; Teh M; Skanderup AJ; Teh BT; Tan P
Gut; 2023 Feb; 72(2):226-241. PubMed ID: 35817555
[TBL] [Abstract][Full Text] [Related]
4. High-throughput and quantitative assessment of enhancer activity in mammals by CapStarr-seq.
Vanhille L; Griffon A; Maqbool MA; Zacarias-Cabeza J; Dao LT; Fernandez N; Ballester B; Andrau JC; Spicuglia S
Nat Commun; 2015 Apr; 6():6905. PubMed ID: 25872643
[TBL] [Abstract][Full Text] [Related]
5. A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks.
Yuan C; Chen H; Tu S; Huang HY; Pan Y; Gui X; Kuang M; Shen X; Zheng Q; Zhang Y; Cheng C; Hong H; Tao X; Peng Y; Yao X; Meng F; Ji H; Shao Z; Sun Y
Genome Biol; 2021 May; 22(1):156. PubMed ID: 34001209
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide profiling of histone H3K27 acetylation featured fatty acid signalling in pancreatic beta cells in diet-induced obesity in mice.
Nammo T; Udagawa H; Funahashi N; Kawaguchi M; Uebanso T; Hiramoto M; Nishimura W; Yasuda K
Diabetologia; 2018 Dec; 61(12):2608-2620. PubMed ID: 30284014
[TBL] [Abstract][Full Text] [Related]
7. The hyper-activation of transcriptional enhancers in breast cancer.
Li QL; Wang DY; Ju LG; Yao J; Gao C; Lei PJ; Li LY; Zhao XL; Wu M
Clin Epigenetics; 2019 Mar; 11(1):48. PubMed ID: 30867030
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-positive gastric cancer involves enhancer activation through activating transcription factor 3.
Asakawa Y; Okabe A; Fukuyo M; Li W; Ikeda E; Mano Y; Funata S; Namba H; Fujii T; Kita K; Matsusaka K; Kaneda A
Cancer Sci; 2020 May; 111(5):1818-1828. PubMed ID: 32119176
[TBL] [Abstract][Full Text] [Related]
9. Functional assessment of human enhancer activities using whole-genome STARR-sequencing.
Liu Y; Yu S; Dhiman VK; Brunetti T; Eckart H; White KP
Genome Biol; 2017 Nov; 18(1):219. PubMed ID: 29151363
[TBL] [Abstract][Full Text] [Related]
10. The super-enhancer repertoire in porcine liver.
Zhang Y; Zhang J; Wang C; Dai H; Du X; Li Q; Pan Z
J Anim Sci; 2023 Jan; 101():. PubMed ID: 36800318
[TBL] [Abstract][Full Text] [Related]
11. Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity.
Ooi WF; Xing M; Xu C; Yao X; Ramlee MK; Lim MC; Cao F; Lim K; Babu D; Poon LF; Lin Suling J; Qamra A; Irwanto A; Qu Zhengzhong J; Nandi T; Lee-Lim AP; Chan YS; Tay ST; Lee MH; Davies JO; Wong WK; Soo KC; Chan WH; Ong HS; Chow P; Wong CY; Rha SY; Liu J; Hillmer AM; Hughes JR; Rozen S; Teh BT; Fullwood MJ; Li S; Tan P
Nat Commun; 2016 Sep; 7():12983. PubMed ID: 27677335
[TBL] [Abstract][Full Text] [Related]
12. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
[TBL] [Abstract][Full Text] [Related]
13. Enhancer identification in mouse embryonic stem cells using integrative modeling of chromatin and genomic features.
Chen CY; Morris Q; Mitchell JA
BMC Genomics; 2012 Apr; 13():152. PubMed ID: 22537144
[TBL] [Abstract][Full Text] [Related]
14. Opening up the blackbox: an interpretable deep neural network-based classifier for cell-type specific enhancer predictions.
Kim SG; Theera-Ampornpunt N; Fang CH; Harwani M; Grama A; Chaterji S
BMC Syst Biol; 2016 Aug; 10 Suppl 2(Suppl 2):54. PubMed ID: 27490187
[TBL] [Abstract][Full Text] [Related]
15. Histone ChIP-Seq identifies differential enhancer usage during chondrogenesis as critical for defining cell-type specificity.
Cheung K; Barter MJ; Falk J; Proctor CJ; Reynard LN; Young DA
FASEB J; 2020 Apr; 34(4):5317-5331. PubMed ID: 32058623
[TBL] [Abstract][Full Text] [Related]
16. Integrated epigenomic analyses of enhancer as well as promoter regions in gastric cancer.
Baek SJ; Kim M; Bae DH; Kim JH; Kim HJ; Han ME; Oh SO; Kim YS; Kim SY
Oncotarget; 2016 May; 7(18):25620-31. PubMed ID: 27016420
[TBL] [Abstract][Full Text] [Related]
17. Aberrant activation of CYR61 enhancers in colorectal cancer development.
Xie L; Song X; Lin H; Chen Z; Li Q; Guo T; Xu T; Su T; Xu M; Chang X; Wang LK; Liang B; Huang D
J Exp Clin Cancer Res; 2019 May; 38(1):213. PubMed ID: 31118064
[TBL] [Abstract][Full Text] [Related]
18.
Yao X; Tan J; Lim KJ; Koh J; Ooi WF; Li Z; Huang D; Xing M; Chan YS; Qu JZ; Tay ST; Wijaya G; Lam YN; Hong JH; Lee-Lim AP; Guan P; Ng MSW; He CZ; Lin JS; Nandi T; Qamra A; Xu C; Myint SS; Davies JOJ; Goh JY; Loh G; Tan BC; Rozen SG; Yu Q; Tan IBH; Cheng CWS; Li S; Chang KTE; Tan PH; Silver DL; Lezhava A; Steger G; Hughes JR; Teh BT; Tan P
Cancer Discov; 2017 Nov; 7(11):1284-1305. PubMed ID: 28893800
[TBL] [Abstract][Full Text] [Related]
19. Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.
Ryan RJ; Drier Y; Whitton H; Cotton MJ; Kaur J; Issner R; Gillespie S; Epstein CB; Nardi V; Sohani AR; Hochberg EP; Bernstein BE
Cancer Discov; 2015 Oct; 5(10):1058-71. PubMed ID: 26229090
[TBL] [Abstract][Full Text] [Related]
20. DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300.
Kim HJ; Moon SJ; Hong S; Won HH; Kim JH
Nucleic Acids Res; 2022 Aug; 50(14):7873-7888. PubMed ID: 35801925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
